Casdin Capital, LLC Standard Biotools Inc. Transaction History
Casdin Capital, LLC
- $1.29 Billion
- Q3 2024
A detailed history of Casdin Capital, LLC transactions in Standard Biotools Inc. stock. As of the latest transaction made, Casdin Capital, LLC holds 71,254,677 shares of LAB stock, worth $107 Million. This represents 10.68% of its overall portfolio holdings.
Number of Shares
71,254,677
Previous 63,959,677
11.41%
Holding current value
$107 Million
Previous $113 Million
21.48%
% of portfolio
10.68%
Previous 9.76%
Shares
4 transactions
Others Institutions Holding LAB
# of Institutions
143Shares Held
279MCall Options Held
27.2KPut Options Held
34.1K-
Viking Global Investors LP58.7MShares$88 Million0.44% of portfolio
-
Black Rock Inc. New York, NY21.8MShares$32.6 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA17.3MShares$25.9 Million0.0% of portfolio
-
Morgan Stanley New York, NY15.2MShares$22.9 Million0.0% of portfolio
-
Sumitomo Mitsui Trust Holdings, Inc.9.58MShares$14.4 Million0.01% of portfolio
About STANDARD BIOTOOLS INC.
- Ticker LAB
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 78,654,800
- Market Cap $118M
- Description
- Standard BioTools Inc. creates, manufactures, and markets instruments, consumables, reagents, and software for researchers and clinical laboratories worldwide. It offers analytical systems, such as Helios, a CyTOF system, as well as Hyperion imaging systems, Hyperion tissue imagers, and flow conductors; and assays and reagents, including Maxpar ...